The decrease in the proportion of MoKCs in the KC pool increases the cholesterol content in the liver and aggravates hypercholesterolemia, leading to accelerated atherosclerotic plaque development, confirming how overall KC homeostasis is disrupted in hypercholesterolemia, altering plasma cholesterol control, and increasing atherosclerosis. The gene discussed is CALCA; the disease is familial hypercholesterolemia.